Difficulty: Medium
Average Score: 81%
Practice
Concerning argatroban (direct thrombin inhibitor), the following is Wrong:
Correct answer
C
Rationale
In this NCLEX question on argatroban, the correct answer is C) Its level can be monitored by INR. This is because argatroban's anticoagulant effect is best monitored by aPTT (activated partial thromboplastin time) rather than INR (international normalized ratio).
Option A) Given intravenously is correct as argatroban is indeed administered intravenically. Option B) Used in heparin-induced thrombocytopenia is correct as argatroban is specifically indicated for use in patients with heparin-induced thrombocytopenia. Option D) Not antagonized by protamine sulfate is also correct as protamine sulfate is not effective in reversing the anticoagulant effects of argatroban.
Educationally, understanding the monitoring parameters and reversal agents for different anticoagulants is crucial for safe and effective patient care. Knowing the specific indications, administration routes, and monitoring parameters for drugs like argatroban is essential for nurses and healthcare professionals working with patients receiving anticoagulation therapy. This knowledge ensures proper dosing, monitoring, and management of potential complications related to these medications.
Option A) Given intravenously is correct as argatroban is indeed administered intravenically. Option B) Used in heparin-induced thrombocytopenia is correct as argatroban is specifically indicated for use in patients with heparin-induced thrombocytopenia. Option D) Not antagonized by protamine sulfate is also correct as protamine sulfate is not effective in reversing the anticoagulant effects of argatroban.
Educationally, understanding the monitoring parameters and reversal agents for different anticoagulants is crucial for safe and effective patient care. Knowing the specific indications, administration routes, and monitoring parameters for drugs like argatroban is essential for nurses and healthcare professionals working with patients receiving anticoagulation therapy. This knowledge ensures proper dosing, monitoring, and management of potential complications related to these medications.